AAAAAA
Results:
1-11
|
Results: 11
Authors:
Valteau-Couanet, D
Angevin, E
Leboulaire, C
Beaussier, PS
Bayle, C
Hartmann, O
Beaujean, F
Citation: D. Valteau-couanet et al., In vitro generation of cytotoxic effecters activated by interleukin 2 (IL-2): comparison of autologous peripheral blood stem cells (PBSC) from adultsand children, BONE MAR TR, 27(8), 2001, pp. 869-875
Authors:
Vassal, G
Tranchand, B
Valteau-Couanet, D
Mahe, C
Couanet, D
Schoeppfer, C
Grill, J
Kalifa, C
Hill, C
Ardiet, C
Hartmann, O
Citation: G. Vassal et al., Pharmacodynamics of tandem high-dose melphalan with peripheral blood stem cell transplantation in children with neuroblastoma and medulloblastoma, BONE MAR TR, 27(5), 2001, pp. 471-477
Authors:
Raguenez, G
Douc-Rasy, S
Blanc, E
Goldschneider, D
Barrois, M
Valteau-Couanet, D
Benard, J
Citation: G. Raguenez et al., A functional gene map is required to adapt therapy of metastatic neuroblastoma, B CANCER, 88(3), 2001, pp. 295-304
Authors:
Valent, A
Benard, J
Clausse, B
Barrois, M
Valteau-Couanet, D
Terrier-Lacombe, MJ
Spengler, B
Bernheim, A
Citation: A. Valent et al., In vivo elimination of acentric double minutes containing amplified MYCN from neuroblastoma tumor cells through the formation of micronuclei, AM J PATH, 158(5), 2001, pp. 1579-1584
Authors:
Oberlin, O
Brugieres, L
Patte, C
Kalifa, C
Vassal, G
Valteau-Couanet, D
Hartmann, O
Citation: O. Oberlin et al., Recent progress in pediatric oncology., ARCH PED, 7(8), 2000, pp. 866-878
Authors:
Plantaz, D
Michon, J
Valteau-Couanet, D
Coze, C
Chastagner, P
Bergeron, C
Nelken, B
Martelli, H
Peyroulet, MC
Carpentier, AF
Armari-Alla, C
Pagnier, A
Rubie, H
Citation: D. Plantaz et al., Long-term outcome in children with opsoclonus-myoclonus associated with localized neuroblastoma: a report from the French Society of Pediatric Oncology, ARCH PED, 7(6), 2000, pp. 621-628
Authors:
Valteau-Couanet, D
Benhamou, E
Vassal, G
Stambouli, F
Lapierre, V
Couanet, D
Lumbroso, J
Hartmann, O
Citation: D. Valteau-couanet et al., Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastoma, BONE MAR TR, 25(9), 2000, pp. 937-942
Authors:
Le Cesne, A
Vassal, G
Farace, F
Spielmann, M
Le Chevalier, T
Angevin, E
Valteau-Couanet, D
Fizazi, K
Cojean, I
Llombard, A
Tursz, T
Escudier, B
Citation: A. Le Cesne et al., Combination interleukin-2 and doxorubicin in advanced adult solid tumors: Circumvention of doxorubicin resistance in soft-tissue sarcoma?, J IMMUNOTH, 22(3), 1999, pp. 268-277
Authors:
Hartmann, O
Valteau-Couanet, D
Vassal, G
Lapierre, V
Brugieres, L
Delgado, R
Couanet, D
Lumbroso, J
Benhamou, E
Citation: O. Hartmann et al., Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institution, BONE MAR TR, 23(8), 1999, pp. 789-795
Authors:
Boland, I
Vassal, G
Morizet, J
Terrier-Lacombe, MJ
Valteau-Couanet, D
Kalifa, C
Hartmann, O
Gouyette, A
Citation: I. Boland et al., Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations, BR J CANC, 79(5-6), 1999, pp. 787-792
Authors:
Teinturier, C
Hartmann, O
Valteau-Couanet, D
Benhamou, E
Bougneres, PF
Citation: C. Teinturier et al., Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure, BONE MAR TR, 22(10), 1998, pp. 989-994
Risultati:
1-11
|